$IDRA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IDERA PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IDERA PHARMACEUTICALS, INC.. Get notifications about new insider transactions in IDERA PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 10 2021 | IDRA | IDERA PHARMACEUTIC ... | GOWEN MAXINE | Option Exercise | A | 1.31 | 26,000 | 34,060 | 26,000 | ||
Mar 31 2021 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Option Exercise | X | 0.01 | 884,175 | 8,842 | 884,175 | |
Mar 31 2021 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Option Exercise | X | 0.01 | 1,611,634 | 16,116 | 1,611,634 | |
Mar 31 2021 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Option Exercise | X | 0.01 | 643,525 | 6,435 | 643,525 | |
Mar 31 2021 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Buy | X | 0.01 | 884,175 | 8,842 | 2,492,342 | 1.6 M to 2.5 M (+54.98 %) |
Mar 31 2021 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Buy | X | 0.01 | 1,611,634 | 16,116 | 5,733,233 | 4.1 M to 5.7 M (+39.10 %) |
Mar 31 2021 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Buy | S | 1.80 | 323,726 | 582,221 | 1,608,167 | 1.3 M to 1.6 M (+25.20 %) |
Mar 31 2021 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Buy | S | 1.80 | 1,376,039 | 2,474,806 | 4,121,599 | 2.7 M to 4.1 M (+50.12 %) |
Mar 31 2021 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Option Exercise | X | 0.01 | 884,175 | 8,842 | 884,175 | |
Mar 31 2021 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Buy | X | 0.01 | 643,525 | 6,435 | 1,931,893 | 1.3 M to 1.9 M (+49.95 %) |
Mar 31 2021 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Option Exercise | X | 0.01 | 1,611,634 | 16,116 | 1,611,634 | |
Mar 31 2021 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Option Exercise | X | 0.01 | 643,525 | 6,435 | 643,525 | |
Mar 31 2021 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Buy | X | 0.01 | 884,175 | 8,842 | 2,492,342 | 1.6 M to 2.5 M (+54.98 %) |
Mar 31 2021 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Buy | X | 0.01 | 1,611,634 | 16,116 | 5,733,233 | 4.1 M to 5.7 M (+39.10 %) |
Mar 31 2021 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Buy | S | 1.80 | 323,726 | 582,221 | 1,608,167 | 1.3 M to 1.6 M (+25.20 %) |
Mar 31 2021 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Buy | S | 1.80 | 1,376,039 | 2,474,806 | 4,121,599 | 2.7 M to 4.1 M (+50.12 %) |
Mar 31 2021 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Buy | X | 0.01 | 643,525 | 6,435 | 1,931,893 | 1.3 M to 1.9 M (+49.95 %) |
Mar 29 2021 | IDRA | IDERA PHARMACEUTIC ... | Tarka Elizabeth Ann | CHIEF MEDICAL OFFIC ... | Sell | S | 1.35 | 5,018 | 6,778 | 13,237 | 18.3 K to 13.2 K (-27.49 %) |
Mar 29 2021 | IDRA | IDERA PHARMACEUTIC ... | Lim Bryant David | SVP AND GENERAL COU ... | Sell | S | 1.36 | 7,630 | 10,378 | 30,434 | 38.1 K to 30.4 K (-20.05 %) |
Mar 29 2021 | IDRA | IDERA PHARMACEUTIC ... | Kirby John J. | CHIEF FINANCIAL OFF ... | Sell | S | 1.42 | 6,250 | 8,876 | 27,632 | 33.9 K to 27.6 K (-18.45 %) |
Mar 05 2021 | IDRA | IDERA PHARMACEUTIC ... | SOLAND DANIEL B | CHIEF OPERATING OFF ... | Buy | P | 3.90 | 10,000 | 38,950 | 28,843 | 18.8 K to 28.8 K (+53.07 %) |
Jan 12 2021 | IDRA | IDERA PHARMACEUTIC ... | Kirby John J. | Chief Financial Off ... | Option Exercise | A | 4.28 | 51,000 | 218,280 | 51,000 | |
Jan 12 2021 | IDRA | IDERA PHARMACEUTIC ... | Kirby John J. | Chief Financial Off ... | Sell | S | 4.22 | 1,693 | 7,152 | 33,882 | 35.6 K to 33.9 K (-4.76 %) |
Jan 12 2021 | IDRA | IDERA PHARMACEUTIC ... | Tarka Elizabeth Ann | Chief Medical Offic ... | Option Exercise | A | 4.28 | 51,000 | 218,280 | 51,000 | |
Jan 12 2021 | IDRA | IDERA PHARMACEUTIC ... | Tarka Elizabeth Ann | Chief Medical Offic ... | Sell | S | 4.19 | 1,745 | 7,310 | 18,255 | 20 K to 18.3 K (-8.72 %) |
Jan 12 2021 | IDRA | IDERA PHARMACEUTIC ... | Lim Bryant David | SVP and General Cou ... | Option Exercise | A | 4.28 | 51,000 | 218,280 | 51,000 | |
Jan 12 2021 | IDRA | IDERA PHARMACEUTIC ... | Lim Bryant David | SVP and General Cou ... | Sell | S | 4.21 | 1,711 | 7,202 | 38,064 | 39.8 K to 38.1 K (-4.30 %) |
Jan 12 2021 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Option Exercise | A | 4.28 | 95,000 | 406,600 | 95,000 | |
Jan 12 2021 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Sell | S | 4.20 | 3,210 | 13,474 | 208,611 | 211.8 K to 208.6 K (-1.52 %) |
Jan 11 2021 | IDRA | IDERA PHARMACEUTIC ... | Lim Bryant David | SVP and General Cou ... | Sell | S | 3.91 | 1,465 | 5,722 | 39,775 | 41.2 K to 39.8 K (-3.55 %) |
Jan 11 2021 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Sell | S | 3.91 | 2,740 | 10,700 | 211,821 | 214.6 K to 211.8 K (-1.28 %) |
Jan 06 2021 | IDRA | IDERA PHARMACEUTIC ... | Kirby John J. | Chief Financial Off ... | Sell | S | 3.90 | 862 | 3,362 | 35,575 | 36.4 K to 35.6 K (-2.37 %) |
Jan 06 2021 | IDRA | IDERA PHARMACEUTIC ... | SCHAFER CAROL | Director | Grant | A | 4.02 | 3,620 | 14,552 | 48,488 | 44.9 K to 48.5 K (+8.07 %) |
Jan 06 2021 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Grant | A | 4.02 | 3,452 | 13,877 | 38,099 | 34.6 K to 38.1 K (+9.96 %) |
Jan 06 2021 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Grant | A | 4.02 | 4,851 | 19,501 | 104,770 | 99.9 K to 104.8 K (+4.85 %) |
Jan 06 2021 | IDRA | IDERA PHARMACEUTIC ... | DOUGHERTY MICHAEL R | Director | Grant | A | 4.02 | 3,515 | 14,130 | 37,645 | 34.1 K to 37.6 K (+10.30 %) |
Jan 05 2021 | IDRA | IDERA PHARMACEUTIC ... | SOLAND DANIEL B | Chief Operating Off ... | Option Exercise | A | 4.02 | 200,000 | 804,000 | 200,000 | |
Jan 05 2021 | IDRA | IDERA PHARMACEUTIC ... | SOLAND DANIEL B | Chief Operating Off ... | Option Exercise | A | 4.02 | 200,000 | 804,000 | 200,000 | |
Dec 22 2020 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Sell | S | 4.32 | 37,169 | 160,525 | 214,561 | 251.7 K to 214.6 K (-14.77 %) |
Dec 22 2020 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Grant | A | 0.00 | 128,170 | 0 | 251,730 | 123.6 K to 251.7 K (+103.73 %) |
Dec 15 2020 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Option Exercise | P | 0.00 | 766,941 | 0 | 766,941 | |
Dec 15 2020 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Option Exercise | P | 0.00 | 606,885 | 0 | 606,885 | |
Dec 15 2020 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Option Exercise | P | 0.00 | 1,533,883 | 0 | 1,533,883 | |
Dec 15 2020 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Option Exercise | P | 0.00 | 1,143,428 | 0 | 1,143,428 | |
Dec 15 2020 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Buy | P | 1.82 | 69,941 | 127,293 | 5,497,638 | 5.4 M to 5.5 M (+1.29 %) |
Oct 05 2020 | IDRA | IDERA PHARMACEUTIC ... | SCHAFER CAROL | Director | Grant | A | 2.25 | 6,111 | 13,750 | 44,868 | 38.8 K to 44.9 K (+15.77 %) |
Oct 05 2020 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Grant | A | 2.25 | 5,583 | 12,562 | 45,457 | 39.9 K to 45.5 K (+14.00 %) |
Oct 05 2020 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Grant | A | 2.25 | 6,166 | 13,874 | 34,647 | 28.5 K to 34.6 K (+21.65 %) |
Oct 05 2020 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Grant | A | 2.25 | 8,666 | 19,499 | 99,919 | 91.3 K to 99.9 K (+9.50 %) |
Sep 04 2020 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Option Exercise | P | 0.00 | 3,039,514 | 0 | 3,039,514 | |
Sep 04 2020 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | J | 0.00 | 103,891 | 0 | 1,288,368 | 1.4 M to 1.3 M (-7.46 %) |
Sep 04 2020 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | J | 0.00 | 46,304 | 0 | 5,427,697 | 5.5 M to 5.4 M (-0.85 %) |
Jul 23 2020 | IDRA | IDERA PHARMACEUTIC ... | Tarka Elizabeth Ann | Chief Medical Offic ... | Option Exercise | A | 2.48 | 50,000 | 124,000 | 50,000 | |
Jul 23 2020 | IDRA | IDERA PHARMACEUTIC ... | Lim Bryant David | SVP and General Cou ... | Option Exercise | A | 2.48 | 50,000 | 124,000 | 50,000 | |
Jul 23 2020 | IDRA | IDERA PHARMACEUTIC ... | Kirby John J. | Chief Financial Off ... | Option Exercise | A | 2.48 | 50,000 | 124,000 | 50,000 | |
Jul 23 2020 | IDRA | IDERA PHARMACEUTIC ... | Fletcher Robert C. | Sr. VP, Bus. Dev. & ... | Option Exercise | A | 2.48 | 50,000 | 124,000 | 50,000 | |
Jul 23 2020 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Option Exercise | A | 2.48 | 92,000 | 228,160 | 92,000 | |
Jul 15 2020 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Option Exercise | P | 0.00 | 2,764,227 | 0 | 2,764,227 | |
Jul 15 2020 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Option Exercise | P | 0.00 | 2,014,234 | 0 | 2,014,234 | |
Jul 15 2020 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Buy | P | 1.72 | 749,993 | 1,289,988 | 5,427,697 | 4.7 M to 5.4 M (+16.03 %) |
Jul 02 2020 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Grant | A | 1.79 | 7,018 | 12,562 | 39,874 | 32.9 K to 39.9 K (+21.36 %) |
Jul 02 2020 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Grant | A | 1.79 | 7,751 | 13,874 | 28,481 | 20.7 K to 28.5 K (+37.39 %) |
Jul 02 2020 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Grant | A | 1.79 | 10,894 | 19,500 | 91,253 | 80.4 K to 91.3 K (+13.56 %) |
Jul 02 2020 | IDRA | IDERA PHARMACEUTIC ... | DOUGHERTY MICHAEL R | Director | Grant | A | 1.79 | 7,193 | 12,875 | 28,408 | 21.2 K to 28.4 K (+33.91 %) |
Jul 02 2020 | IDRA | IDERA PHARMACEUTIC ... | SCHAFER CAROL | Director | Grant | A | 1.79 | 7,681 | 13,749 | 38,757 | 31.1 K to 38.8 K (+24.72 %) |
May 19 2020 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Option Exercise | A | 1.97 | 14,500 | 28,565 | 14,500 | |
May 19 2020 | IDRA | IDERA PHARMACEUTIC ... | SCHAFER CAROL | Director | Option Exercise | A | 1.97 | 11,500 | 22,655 | 11,500 | |
May 19 2020 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Option Exercise | A | 1.97 | 11,500 | 22,655 | 11,500 | |
May 19 2020 | IDRA | IDERA PHARMACEUTIC ... | GOWEN MAXINE | Director | Option Exercise | A | 1.97 | 11,500 | 22,655 | 11,500 | |
May 19 2020 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Option Exercise | A | 1.97 | 11,500 | 22,655 | 11,500 | |
May 19 2020 | IDRA | IDERA PHARMACEUTIC ... | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 1.97 | 11,500 | 22,655 | 11,500 | |
May 19 2020 | IDRA | IDERA PHARMACEUTIC ... | Csimma Cristina | Director | Option Exercise | A | 1.97 | 11,500 | 22,655 | 11,500 | |
Apr 09 2020 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Buy | P | 1.52 | 3,039,514 | 4,620,061 | 6,260,832 | 3.2 M to 6.3 M (+94.36 %) |
Apr 03 2020 | IDRA | IDERA PHARMACEUTIC ... | SCHAFER CAROL | Director | Grant | A | 1.28 | 10,633 | 13,610 | 31,076 | 20.4 K to 31.1 K (+52.01 %) |
Apr 03 2020 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Grant | A | 1.28 | 9,666 | 12,372 | 32,856 | 23.2 K to 32.9 K (+41.68 %) |
Apr 03 2020 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Grant | A | 1.28 | 10,730 | 13,734 | 20,730 | 10 K to 20.7 K (+107.30 %) |
Apr 03 2020 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Grant | A | 1.28 | 14,926 | 19,105 | 80,359 | 65.4 K to 80.4 K (+22.81 %) |
Apr 03 2020 | IDRA | IDERA PHARMACEUTIC ... | DOUGHERTY MICHAEL R | Director | Grant | A | 1.28 | 10,059 | 12,876 | 21,215 | 11.2 K to 21.2 K (+90.17 %) |
Feb 26 2020 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 1.76 | 17,250 | 30,438 | 3,254,442 | 3.3 M to 3.3 M (-0.53 %) |
Feb 26 2020 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 1.76 | 12,532 | 22,081 | 3,271,692 | 3.3 M to 3.3 M (-0.38 %) |
Feb 26 2020 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 1.77 | 15,000 | 26,550 | 3,284,224 | 3.3 M to 3.3 M (-0.45 %) |
Jan 14 2020 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Option Exercise | A | 1.79 | 50,000 | 89,500 | 50,000 | |
Jan 14 2020 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Grant | A | 0.00 | 20,000 | 0 | 36,358 | 16.4 K to 36.4 K (+122.26 %) |
Jan 14 2020 | IDRA | IDERA PHARMACEUTIC ... | Tarka Elizabeth Ann | Chief Medical Offic ... | Option Exercise | A | 1.79 | 50,000 | 89,500 | 50,000 | |
Jan 14 2020 | IDRA | IDERA PHARMACEUTIC ... | Tarka Elizabeth Ann | Chief Medical Offic ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Jan 14 2020 | IDRA | IDERA PHARMACEUTIC ... | Lim Bryant David | SVP and General Cou ... | Option Exercise | A | 1.79 | 50,000 | 89,500 | 50,000 | |
Jan 14 2020 | IDRA | IDERA PHARMACEUTIC ... | Lim Bryant David | SVP and General Cou ... | Grant | A | 0.00 | 20,000 | 0 | 41,240 | 21.2 K to 41.2 K (+94.16 %) |
Jan 14 2020 | IDRA | IDERA PHARMACEUTIC ... | Fletcher Robert C. | Sr. VP, Bus. Dev. & ... | Option Exercise | A | 1.79 | 50,000 | 89,500 | 50,000 | |
Jan 14 2020 | IDRA | IDERA PHARMACEUTIC ... | Fletcher Robert C. | Sr. VP, Bus. Dev. & ... | Grant | A | 0.00 | 20,000 | 0 | 36,485 | 16.5 K to 36.5 K (+121.32 %) |
Jan 14 2020 | IDRA | IDERA PHARMACEUTIC ... | Kirby John J. | Chief Financial Off ... | Option Exercise | A | 1.79 | 50,000 | 89,500 | 50,000 | |
Jan 14 2020 | IDRA | IDERA PHARMACEUTIC ... | Kirby John J. | Chief Financial Off ... | Grant | A | 0.00 | 20,000 | 0 | 36,437 | 16.4 K to 36.4 K (+121.68 %) |
Jan 14 2020 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Option Exercise | A | 1.79 | 92,000 | 164,680 | 92,000 | |
Jan 14 2020 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Grant | A | 0.00 | 37,000 | 0 | 123,560 | 86.6 K to 123.6 K (+42.74 %) |
Jan 10 2020 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Sell | S | 1.78 | 1,742 | 3,101 | 16,358 | 18.1 K to 16.4 K (-9.62 %) |
Jan 10 2020 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Sell | S | 1.78 | 3,006 | 5,352 | 86,560 | 89.6 K to 86.6 K (-3.36 %) |
Jan 10 2020 | IDRA | IDERA PHARMACEUTIC ... | Kirby John J. | Chief Financial Off ... | Sell | S | 1.78 | 911 | 1,622 | 16,437 | 17.3 K to 16.4 K (-5.25 %) |
Jan 10 2020 | IDRA | IDERA PHARMACEUTIC ... | Fletcher Robert C. | Sr. VP, Bus. Dev. & ... | Sell | S | 1.78 | 1,615 | 2,875 | 16,485 | 18.1 K to 16.5 K (-8.92 %) |
Jan 10 2020 | IDRA | IDERA PHARMACEUTIC ... | Lim Bryant David | SVP and General Cou ... | Sell | S | 1.78 | 1,603 | 2,854 | 21,240 | 22.8 K to 21.2 K (-7.02 %) |
Jan 06 2020 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Grant | A | 1.85 | 6,790 | 12,562 | 23,190 | 16.4 K to 23.2 K (+41.40 %) |
Nov 08 2019 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 2.44 | 9,000 | 21,960 | 3,299,224 | 3.3 M to 3.3 M (-0.27 %) |
Nov 08 2019 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 2.45 | 10,000 | 24,500 | 3,308,224 | 3.3 M to 3.3 M (-0.30 %) |
Nov 08 2019 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 2.50 | 100,000 | 249,560 | 3,318,224 | 3.4 M to 3.3 M (-2.93 %) |
Oct 02 2019 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Grant | A | 2.67 | 4,610 | 12,309 | 16,400 | 11.8 K to 16.4 K (+39.10 %) |
Oct 02 2019 | IDRA | IDERA PHARMACEUTIC ... | DOUGHERTY MICHAEL R | Director | Grant | A | 2.67 | 4,119 | 10,998 | 4,119 | 0 to 4.1 K |
Oct 02 2019 | IDRA | IDERA PHARMACEUTIC ... | SCHAFER CAROL | Director | Grant | A | 2.67 | 5,098 | 13,612 | 20,443 | 15.3 K to 20.4 K (+33.22 %) |
Jul 23 2019 | IDRA | IDERA PHARMACEUTIC ... | Tarka Elizabeth Ann | Chief Medical Offic ... | Option Exercise | A | 2.54 | 130,000 | 330,200 | 130,000 | |
Jul 11 2019 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Option Exercise | A | 2.52 | 45,500 | 114,660 | 45,500 | |
Jul 11 2019 | IDRA | IDERA PHARMACEUTIC ... | Kirby John J. | VP of Finance | Option Exercise | A | 2.52 | 45,500 | 114,660 | 45,500 | |
Jul 11 2019 | IDRA | IDERA PHARMACEUTIC ... | Horobin Joanna | Chief Medical Offic ... | Option Exercise | A | 2.52 | 45,500 | 114,660 | 45,500 | |
Jul 11 2019 | IDRA | IDERA PHARMACEUTIC ... | Fletcher Robert C. | Sr. VP, Bus. Dev. & ... | Option Exercise | A | 2.52 | 45,500 | 114,660 | 45,500 | |
Jul 11 2019 | IDRA | IDERA PHARMACEUTIC ... | Lim Bryant David | SVP and General Cou ... | Option Exercise | A | 2.52 | 45,500 | 114,660 | 45,500 | |
Jul 11 2019 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Option Exercise | A | 2.52 | 84,500 | 212,940 | 84,500 | |
Jul 03 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Grant | A | 2.61 | 2,964 | 7,736 | 4,290,995 | 4.3 M to 4.3 M (+0.07 %) |
Jul 03 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Grant | A | 2.61 | 2,964 | 7,736 | 350,721 | 347.8 K to 350.7 K (+0.85 %) |
Jul 02 2019 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Grant | A | 2.61 | 4,469 | 11,664 | 11,790 | 7.3 K to 11.8 K (+61.04 %) |
Jul 02 2019 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Grant | A | 2.61 | 4,469 | 11,664 | 11,790 | 7.3 K to 11.8 K (+61.04 %) |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 880 | 70 | 880 | |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 1,660 | 133 | 1,660 | |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 6,256 | 500 | 6,256 | |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 880 | 70 | 880 | |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 1,660 | 133 | 1,660 | |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 6,256 | 500 | 6,256 | |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 6,009 | 481 | 0 | |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 11,337 | 907 | 0 | |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 42,724 | 3,418 | 0 | |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | J | 0.00 | 21,929 | 0 | 21,929 | 0 to 21.9 K |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | J | 0.00 | 21,929 | 0 | 21,929 | 0 to 21.9 K |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | J | 0.00 | 59,267 | 0 | 0 | 59.3 K to 0 (-100.00 %) |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | J | 0.00 | 178,967 | 0 | 347,757 | 526.7 K to 347.8 K (-33.98 %) |
Jun 06 2019 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Option Exercise | A | 2.57 | 14,500 | 37,265 | 14,500 | |
Jun 06 2019 | IDRA | IDERA PHARMACEUTIC ... | SCHAFER CAROL | Director | Option Exercise | A | 2.57 | 11,500 | 29,555 | 11,500 | |
Jun 06 2019 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Option Exercise | A | 2.57 | 11,500 | 29,555 | 11,500 | |
Jun 06 2019 | IDRA | IDERA PHARMACEUTIC ... | GOWEN MAXINE | Director | Option Exercise | A | 2.57 | 11,500 | 29,555 | 11,500 | |
Jun 06 2019 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Option Exercise | A | 2.57 | 11,500 | 29,555 | 11,500 | |
Jun 06 2019 | IDRA | IDERA PHARMACEUTIC ... | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 2.57 | 11,500 | 29,555 | 11,500 | |
Jun 06 2019 | IDRA | IDERA PHARMACEUTIC ... | Csimma Cristina | Director | Option Exercise | A | 2.57 | 11,500 | 29,555 | 11,500 | |
Apr 10 2019 | IDRA | IDERA PHARMACEUTIC ... | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 2.66 | 23,000 | 61,180 | 23,000 | |
Apr 10 2019 | IDRA | IDERA PHARMACEUTIC ... | Csimma Cristina | Director | Option Exercise | A | 2.66 | 23,000 | 61,180 | 23,000 | |
Apr 03 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.59 | 4,161 | 10,777 | 89,233 | 85.1 K to 89.2 K (+4.89 %) |
Apr 03 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.59 | 4,161 | 10,777 | 4,288,031 | 4.3 M to 4.3 M (+0.10 %) |
Apr 03 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.59 | 4,161 | 10,777 | 526,724 | 522.6 K to 526.7 K (+0.80 %) |
Jan 07 2019 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Option Exercise | A | 3.14 | 45,500 | 142,870 | 45,500 | |
Jan 07 2019 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Grant | A | 0.00 | 18,100 | 0 | 18,100 | 0 to 18.1 K |
Jan 07 2019 | IDRA | IDERA PHARMACEUTIC ... | Horobin Joanna | Chief Medical Offic ... | Option Exercise | A | 3.14 | 45,500 | 142,870 | 45,500 | |
Jan 07 2019 | IDRA | IDERA PHARMACEUTIC ... | Horobin Joanna | Chief Medical Offic ... | Grant | A | 0.00 | 18,100 | 0 | 20,144 | 2 K to 20.1 K (+885.52 %) |
Jan 07 2019 | IDRA | IDERA PHARMACEUTIC ... | Fletcher Robert C. | Sr. VP, Bus. Dev. & ... | Option Exercise | A | 3.14 | 45,500 | 142,870 | 45,500 | |
Jan 07 2019 | IDRA | IDERA PHARMACEUTIC ... | Fletcher Robert C. | Sr. VP, Bus. Dev. & ... | Grant | A | 0.00 | 18,100 | 0 | 18,100 | 0 to 18.1 K |
Jan 07 2019 | IDRA | IDERA PHARMACEUTIC ... | Kirby John J. | VP of Finance | Option Exercise | A | 3.14 | 25,600 | 80,384 | 25,600 | |
Jan 07 2019 | IDRA | IDERA PHARMACEUTIC ... | Kirby John J. | VP of Finance | Grant | A | 0.00 | 10,250 | 0 | 12,509 | 2.3 K to 12.5 K (+453.74 %) |
Jan 07 2019 | IDRA | IDERA PHARMACEUTIC ... | Lim Bryant David | SVP and General Cou ... | Option Exercise | A | 3.14 | 45,500 | 142,870 | 45,500 |